Live longer.
Skip the noise.
We read the studies, grade every claim, and hand you the signal — so you know what actually works and what's just hype.
Every claim is graded and cited.
We read the studies, check the methodology, and flag conflicts of interest — so you always know exactly how solid the ground is before you act on anything.
Meta-analysis, systematic review, or large replicated trial.
A solid randomized trial or strong observational data.
Preclinical or small pilot — promising, not proven.
Early signal — interesting, but treat with caution.
Explore the research
Supplements & Compounds
What to take, what to skip — with evidence tiers. NMN, NAD+, rapamycin, metformin, and more.
🧪Peptides & Bioregulators
BPC-157, Epitalon, GHK-Cu and the emerging peptide landscape — what's real, what's hype.
💊Brand New Drugs
Just-approved and pipeline drugs that target aging biology directly.
⚡Breaking Now
New studies, trial results, and approvals from the last 30 days.
🔭On the Horizon
Preclinical, Phase I/II, early signals — what's coming next.
🧬The Fundamentals
How aging actually works — hallmarks, mechanisms, and core biology explained.
🌿What's Working Naturally
No pills — diet, exercise, sleep, fasting, and the free stuff that moves the needle.
😴Sleep & Longevity
Why sleep is your body's repair shop, and how to actually get more of it.
🏗️Protocols & Biohacks
Real regimens, tracking, and data-driven self-experimentation.
📖History & Context
How we got here — key discoveries and the scientists who built the field.
🦠The Microbiome
Why your gut bugs control how you age — and what to do about it.
🗣️Community Voices
What's working for real people — case studies and N-of-1 experiments.
This Week in Longevity
Aging clocks do respond to anti-aging treatments — now we know which to trust.
A Nature Medicine study harmonized 51 intervention trials and showed 16 epigenetic clocks plus 94 biomarkers actually move with diet, drugs, and lifestyle.
Robotic knee surgery: no better than conventional — just pricier.
A masked Lancet trial of 339 patients found the Mako robotic-arm system delivered no measurable benefit over standard knee replacement.
How obesity raises cancer risk: stressed fat cells turn into "zombie cells."
A review connects excess fat to premature cellular senescence and the inflammatory SASP that creates a tumor-friendly environment.
Keto and biological age: not one-size-fits-all.
In 58 adults on a 12-week ketogenic diet, the "pace of aging" clock split people into responders and non-responders — and responders felt dramatically better.
The hidden muscle cost of Ozempic-style weight-loss drugs.
A review warns GLP-1 drugs can shrink protein intake enough to trigger "secondary sarcopenia" in older adults — protect your protein and keep lifting.